Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nuvation Bio (NUVB) Invested Capital (2023 - 2025)

Historic Invested Capital for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $331.5 million.

  • Nuvation Bio's Invested Capital fell 3514.5% to $331.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $331.5 million, marking a year-over-year decrease of 3514.5%. This contributed to the annual value of $470.1 million for FY2024, which is 2231.8% down from last year.
  • Nuvation Bio's Invested Capital amounted to $331.5 million in Q3 2025, which was down 3514.5% from $378.5 million recorded in Q2 2025.
  • Nuvation Bio's Invested Capital's 5-year high stood at $641.1 million during Q1 2023, with a 5-year trough of $268.8 million in Q2 2024.
  • For the 3-year period, Nuvation Bio's Invested Capital averaged around $496.5 million, with its median value being $511.1 million (2024).
  • In the last 5 years, Nuvation Bio's Invested Capital crashed by 5696.23% in 2024 and then surged by 4079.31% in 2025.
  • Over the past 3 years, Nuvation Bio's Invested Capital (Quarter) stood at $605.1 million in 2023, then dropped by 22.32% to $470.1 million in 2024, then decreased by 29.48% to $331.5 million in 2025.
  • Its Invested Capital was $331.5 million in Q3 2025, compared to $378.5 million in Q2 2025 and $425.1 million in Q1 2025.